Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16018 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Maria Luisa Faquetti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Zurich, Switzerland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Primary Health Care, Polypharmacy, Inappropriate Prescribing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
The aim of this study was to estimate the prevalence of potentially inappropriate prescriptions (PIPs) in patients starting their first noninsulin antidiabetic treatment (NIAD) using two explicit process measures of the appropriateness of prescribing in UK primary care, stratified by age and polypharmacy status.
Methods
A descriptive cohort study between 2016 and 2019 was conducted to assess PIPs in patients aged ≥45 years at the start of their first NIAD, stratified by age and polypharmacy status. The American Geriatrics Society Beers criteria 2015 was used for older (≥65 years) patients and the Prescribing Optimally in Middle‐age People's Treatments criteria was used for middle‐aged (45‐64 years) patients. Prevalence of overall PIPs and individual PIPs criteria was reported using the IQVIA Medical Research Data incorporating THIN, a Cegedim Database of anonymized electronic health records in the UK.
Results
Among 28 604 patients initiating NIADs, 18 494 (64.7%) received polypharmacy. In older and middle‐aged patients with polypharmacy, 39.6% and 22.7%, respectively, received ≥1 PIP. At the individual PIP level, long‐term proton pump inhibitors (PPI) use was the most frequent PIP among older adults, and strong opioid without laxatives was the most frequent PIP in middle‐aged patients with polypharmacy (11.1% and 4.1%, respectively).
Conclusions
This study revealed that patients starting NIAD treatment receiving polypharmacy have the potential for pharmacotherapy optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacoepidemiology Group, Institute of Pharmaceutical Sciences, Zurich, Switzerland.
- Hospital Pharmacy, Kantonsspital Baden, Baden, Switzerland.
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Maria Luisa Faquetti, Dominik Stämpfli, Stefan Weiler, Andrea M Burden
Zitieren
APA
Faquetti, M. L., Frey, G., Stämpfli, D., Weiler, S., & Burden, A. M. (2024). Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16018
Vancouver
Faquetti ML, Frey G, Stämpfli D, Weiler S, Burden AM. Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16018
BibTeX
@article{Faquetti2024,
author = {Faquetti, Maria Luisa and Frey, Géraldine and Stämpfli, Dominik and Weiler, Stefan and Burden, Andrea M},
title = {Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16018}
}
EUVIMED